182 related articles for article (PubMed ID: 12099175)
1. RPA continues advocacy on vitamin D for dialysis.
Singer D; Blaser R
Nephrol News Issues; 2001 Nov; 15(12):13. PubMed ID: 12099175
[No Abstract] [Full Text] [Related]
2. In this issue of "Nephrology, Dialysis, Transplantation".
Nephrol Dial Transplant; 2008 Jun; 23(6):i. PubMed ID: 18492977
[No Abstract] [Full Text] [Related]
3. RPA defines minimal frequency for nephrologist/ESRD-dialysis patient contact.
Clin Nephrol; 2000 May; 53(5):409-10. PubMed ID: 11305818
[No Abstract] [Full Text] [Related]
4. ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities.
Sedor JR; Watnick S; Patel UD; Cheung A; Harmon W; Himmelfarb J; Hostetter TH; Inrig JK; Mehrotra R; Robinson E; Smedberg PC; Shaffer RN;
J Am Soc Nephrol; 2010 Aug; 21(8):1235-7. PubMed ID: 20675502
[No Abstract] [Full Text] [Related]
5. When is Vitamin D contraindicated in dialysis patients?
Evenepoel P
Semin Dial; 2009; 22(3):242-4. PubMed ID: 19572999
[No Abstract] [Full Text] [Related]
6. When is Vitamin D contraindicated in dialysis patients?
Lewin E; Olgaard K
Semin Dial; 2009; 22(3):240-2. PubMed ID: 19572998
[No Abstract] [Full Text] [Related]
7. When is Vitamin D contraindicated in dialysis patients?
Brown HJ; Cunningham J
Semin Dial; 2009; 22(3):237-40. PubMed ID: 19572997
[No Abstract] [Full Text] [Related]
8. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.
St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ
Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585
[TBL] [Abstract][Full Text] [Related]
9. Helping patients with end-stage renal disease.
Kuchta K; VanBuskirk S; Houglum M
Am J Nurs; 2007 May; 107(5):35-6. PubMed ID: 17443073
[No Abstract] [Full Text] [Related]
10. Taking capitation to the nephrologist: an update on the RPA project.
White MG
Nephrol News Issues; 1996 Apr; 10(4):27, 39. PubMed ID: 8716018
[No Abstract] [Full Text] [Related]
11. NKF and RPA collaborating on clinical practice guidelines for chronic kidney disease.
Eknoyan G; Levin N; Nissenson A; Owen W; Levey AS; Bolton K
Nephrol News Issues; 2001 Jul; 15(8):13, 54. PubMed ID: 12099224
[No Abstract] [Full Text] [Related]
12. Vitamin D treatment in chronic kidney disease.
Andress DL
Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
[TBL] [Abstract][Full Text] [Related]
13. Use of vitamin D and its derivatives in chronic renal failure.
Cunningham J
Adv Nephrol Necker Hosp; 1999; 29():207-19. PubMed ID: 10561746
[No Abstract] [Full Text] [Related]
14. CKD initiative now in the hands of renal societies.
Parker TF; Kliger A
Nephrol News Issues; 2003 Aug; 17(9):34-5, 51. PubMed ID: 12971224
[No Abstract] [Full Text] [Related]
15. [Role of vitamin D and its analogues in dialysis patients: beyond PTH control].
Cozzolino M
G Ital Nefrol; 2007; 24(2):107. PubMed ID: 17458822
[No Abstract] [Full Text] [Related]
16. RPA meeting to focus on delivering safe renal care.
Singer D
Nephrol News Issues; 2001 Feb; 15(3):46. PubMed ID: 12098969
[No Abstract] [Full Text] [Related]
17. Ten years of KDOQI.
Neumann ME
Nephrol News Issues; 2012 Nov; 26(12):12. PubMed ID: 23472548
[No Abstract] [Full Text] [Related]
18. Who should be paying for vitamin D analogues--Medicare or the patients?
Grotegut J
Nephrol Nurs J; 2006; 33(3):345-6. PubMed ID: 16912996
[No Abstract] [Full Text] [Related]
19. Dialysis modality distribution in the United States.
Mendelssohn DC; Blake PG; Burkart J; Golper T; Oreopoulous D
Am J Kidney Dis; 2001 Jun; 37(6):1330-1. PubMed ID: 11382710
[No Abstract] [Full Text] [Related]
20. A buying slowdown? TRC continues expansion, but some providers slow acquisition efforts.
Neumann ME
Nephrol News Issues; 1999 Jul; 13(7):30-1. PubMed ID: 10647367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
